CLBT vs. NABL, LSPD, MQ, INST, AVPT, MTTR, COUR, MLNK, CXM, and AMPL
Should you be buying Cellebrite DI stock or one of its competitors? The main competitors of Cellebrite DI include N-able (NABL), Lightspeed Commerce (LSPD), Marqeta (MQ), Instructure (INST), AvePoint (AVPT), Matterport (MTTR), Coursera (COUR), MeridianLink (MLNK), Sprinklr (CXM), and Amplitude (AMPL). These companies are all part of the "prepackaged software" industry.
Cellebrite DI (NASDAQ:CLBT) and N-able (NYSE:NABL) are both mid-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, valuation, dividends, profitability, earnings, analyst recommendations and risk.
In the previous week, Cellebrite DI and Cellebrite DI both had 5 articles in the media. Cellebrite DI's average media sentiment score of 0.92 beat N-able's score of 0.08 indicating that Cellebrite DI is being referred to more favorably in the media.
Cellebrite DI currently has a consensus target price of $12.42, suggesting a potential upside of 5.67%. N-able has a consensus target price of $15.50, suggesting a potential upside of 22.63%. Given N-able's higher probable upside, analysts clearly believe N-able is more favorable than Cellebrite DI.
N-able has a net margin of 6.27% compared to Cellebrite DI's net margin of -24.94%. Cellebrite DI's return on equity of 173.14% beat N-able's return on equity.
Cellebrite DI has a beta of 1.51, suggesting that its share price is 51% more volatile than the S&P 500. Comparatively, N-able has a beta of 0.4, suggesting that its share price is 60% less volatile than the S&P 500.
N-able has higher revenue and earnings than Cellebrite DI. Cellebrite DI is trading at a lower price-to-earnings ratio than N-able, indicating that it is currently the more affordable of the two stocks.
Cellebrite DI received 6 more outperform votes than N-able when rated by MarketBeat users. However, 63.33% of users gave N-able an outperform vote while only 53.19% of users gave Cellebrite DI an outperform vote.
45.9% of Cellebrite DI shares are owned by institutional investors. Comparatively, 96.4% of N-able shares are owned by institutional investors. 5.7% of Cellebrite DI shares are owned by insiders. Comparatively, 1.4% of N-able shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
Cellebrite DI beats N-able on 9 of the 17 factors compared between the two stocks.
Get Cellebrite DI News Delivered to You Automatically
Sign up to receive the latest news and ratings for CLBT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CLBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cellebrite DI Competitors List
Related Companies and Tools
